PLoS One 10 , e0120982 (2015)
5-alpha-reductase deficiency-2 is biochemically characterized by low to low normal levels of testosterone and decreased levels of 5-DHT, creating a higher testosterone/DHT ratio
We carry and administer the same hospital-grade ingredients, supplies, and equipment with all our drips, boosters, and shots
Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method or add a barrier method of contraception for 4 weeks after initiation and for 4 weeks after each dose escalation with MOUNJARO [see Drug Interactions (7.2) and Clinical Pharmacology (12.2, 12.3)]
International Union of Pharmacology
Route the J1817 claim to the appropriate DME MAC contractor, not the Part B carrier